Patent Oppositions in vaccines and immunity drugs industry

Explore the competitive field of vaccines and immunity drugs where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in vaccines and immunity drugs technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the vaccines and immunity drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the vaccines and immunity drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Oct 1, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Compositions And Methods Of Treating Lupus NephritisGENENTECHSep 30, 2026KERNEBECK PATENTANWALTS
Compositions And Methods Of Treating Lupus NephritisF HOFFMANN LA ROCHESep 30, 2026MAIWALD PATENTANWALTS
Cytotoxicity-Inducing Therapeutic AgentCHUGAI SEIYAKU KABUSHIKI KAISHASep 29, 2026STRAWMAN
Compositions And Methods Of Treating Lupus NephritisGENENTECHSep 29, 2026WUESTHOFF & WUESTHOFF
Compositions And Methods Of Treating Lupus NephritisF HOFFMANN LA ROCHESep 29, 2026WUESTHOFF & WUESTHOFF
Binding Molecules For Bcma And Cd3AMGENSep 18, 2026ABBVIE
Methods Of Treating Crohn'S Disease With Anti-Il23 Specific AntibodyJANSSEN BIOTECHSep 14, 2026SIMMONS & SIMMONS
Formulation For Anti-Alpha4Beta7 AntibodyMILLENNIUM PHARMACEUTICALSSep 10, 2026CAMULON
Formulation For Anti-Alpha4Beta7 AntibodyMILLENNIUM PHARMACEUTICALSSep 9, 2026FRESENIUS KABI SWISSBIOSIM
Formulation For Anti-Alpha4Beta7 AntibodyMILLENNIUM PHARMACEUTICALSSep 4, 2026ABEL & IMRAY

To stay ahead in the competitive vaccines and immunity drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the vaccines and immunity drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Oct 1, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Mar 11, 2015Treatment Of Tnf Alpha Related DisordersABBVIE BIOTECHNOLOGY13
Jan 18, 2017Methods Of Administering Anti-Tnfalpha AntibodiesABBVIE BIOTECHNOLOGY11
Nov 2, 2016Multiple-Variable Dose Regimen For Treating Tnfalpha-Related DisordersABBVIE BIOTECHNOLOGY11
Feb 22, 2017Combination Therapies Employing Gitr Binding MoleculesTOLERX10
Feb 17, 2021Pharmaceutical Composition For Cancer TreatmentOSAKA UNIVERSITY10
Oct 26, 2016Use Of Anti-Vegf Antibody In Combination With Chemotherapy For Treating Breast CancerF HOFFMANN LA ROCHE10
Feb 17, 2021Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of CancerLINDHOFER10
Oct 22, 2014Method For Treating Joint DamageGENENTECH9
May 15, 2019Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF HOFFMANN LA ROCHE9
Jan 13, 2021Method Of Treating Cancer Using Immune Checkpoint InhibitorBRISTOL MYERS SQUIBB9